Michael Voss Email & Phone Number

San Antonio, TX, US

Hand-selected by founder and CEO to lead strategic planning and financial modeling to facilitate product commercialization. Craft commercial and new product development pipeline strategies to accelerate market acceptance, partner with research and development (R&D) teams to harness Voice of the Customer (VoC) insights and drive value-centered messaging and.

Recruited to build surgical and sports medicine franchise from scratch following organizational restructure. Managed 40 staff in 5 departments: strategic marketing, R&D, finance, quality assurance, and regulatory compliance. Optimized an $8M budget. Developed and led execution of multi-year strategic plans and product pipeline roadmap. Forged consultative.

San Diego, CA, US

Oversaw global strategic planning, sales, marketing, and finance for a $240M interventional business. Led 5-member senior leadership team and an 80-member direct salesforce. Crafted innovation-focused growth strategy, identified emerging opportunities, and harnessed team capabilities to raise profitability and financial performance. Achieved #1.

Hired to jumpstart global profitability for startup providing first-of-its-kind battery-powered device for immediate vascular access via intraosseous technology. Oversaw sales, marketing, R&D, operations, manufacturing, and customer service. Initially managed worldwide distributor relationships and steered pivot to direct salesforce. Vaulted global.

Colorado Springs, Colorado, US

Recruited by CEO to oversee the $180M vascular interventions division. Generated 23% sales growth over prior year through promotion of an expanded product line and development and training of a high-caliber sales force. Instituted key opinion leader (KOL) to nurture alliances with product champions and amplify reach at trade shows and physician.

Salt Lake City, Utah, US

Brought on to lead global marketing for 7 product franchises. Directed product portfolio management and rationalization, strategic franchise marketing, and pricing. Increased top-line sales 23% and net income 19% over prior year in 2007 and again delivered double-digit growth in 2008 for business unit’s fastest-growing division. Reimagined portfolio to.

Joined company to oversee marketing for the $508M coronary stent business. In 2003, assumed leadership of a 25-member sales team covering the $120M mid-Atlantic region. Led team to boost sales volume 45% by promoting breakthrough drug-eluting stent that transformed the marketplace and reached $1B in overall sales. Turned around performance of a highly.